You’re using a public version of DrugPatentWatch with 5 free searches available | Register to unlock more free searches. CREATE FREE ACCOUNT

Last Updated: April 26, 2024

Claims for Patent: 3,761,590

✉ Email this page to a colleague

« Back to Dashboard

Summary for Patent: 3,761,590

Title:	SILVER SULFADIAZINE USED IN THE TREATMENT OF BURNS
Abstract:	Silver sulfadiazine has been found to be useful in burn therapy by applying to the affected surface silver sulfadiazine, preferably dispersed in a water-dispersible hydrophilic carrier.
Inventor(s):	Fox, Jr.; Charles L. (New York, NY)
Assignee:	Research Corporation (New York, NY)
Application Number:	05/038,031
Patent Claims:	1. A method of treating burns in man and animal which comprises topically applying an effective anti-bacterial amount of silver sulfadiazine to the affected surface. 2. A method in accordance with claim 1 wherein said silver sulfadiazine is applied as a dispersion in a water-dispersible, hydrophilic carrier. 3. A method in accordance with claim 1 wherein said silver sulfadiazine is applied as a dispersion in a semi-soft or cream-like, water-dispersible or water-soluble oil-in-water emulsion carrier. 4. A method in accordance with claim 1 wherein said silver sulfadiazine is applied as a dispersion in a water-dispersible, hydrophilic carrier, said carrier containing an amount in the range from about 0.1 to about 10 percent by weight of silver sulfadiazine dispersed therein. 5. A method in accordance with claim 1 wherein silver sulfadiazine is applied as a dispersion in a semi-soft or cream-like, water-dispersible or water-soluble oil-in-water emulsion carrier, said carrier containing an amount in the range from about 0.1 to about 10 percent by weight of silver sulfadiazine dispersed therein. 6. A method in accordance with claim 2 wherein said dispersion consists essentially of 0-25 percent by weight petrolatum, 7-45 percent by weight of a long chain fatty alcohol having a carbon atom content in the range C.sub.16 -C.sub.22, 0.1-10 percent by weight silver sulfadiazine, 4-16 percent by weight of a non-ionic emulsifying agent, 7-40 percent by weight of a humectant selected from the group consisting of propylene glycol, sorbitol and glycerin, 0-15 percent by weight of an emollient and an amount of water, when required, sufficient to bring the total of the percentages of the above-identified components to 100 percent.

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.